Direct medical costs of type 2 diabetes and its complications in Switzerland
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: This paper analyses the direct medical costs of type 2 diabetes and its complications in Switzerland. METHODS: Individual healthcare resource consumption related to type 2 diabetes and its complications was determined retrospectively in 1479 non-incident and non-dying patients over 12 months (1998-1999). Literature-derived attributable risks were used to correct for non-diabetes related macrovascular disease. RESULTS: A total of 111 primary care physicians from 19 cantons throughout Switzerland participated. Their diabetic patients on average had 10.3 consultations per year related to this disease (95% CI: 10.0-10.7). Patients spent on average 2.7 days (95% CI: 2.2-3.3) per year in hospital due to diabetes and diabetes-related complications. Mean annual type 2 diabetes-related direct medical costs per patient amounted to CHF 3,508 / Euro 2,323 (95% CI: CHF 3,140-3,876 / Euro 2,080-2,567). They were particularly high in patients with insulin treatment or with complications. After application of attributable risks and a correction for the use of adjuvant materials, costs were CHF 3,324 / Euro 2,201. Assuming 250,000 patients with type 2 diabetes in Switzerland leads to an estimate of CHF 0.88 billion spent for this disease and its complications in 1998. This represents a share of about 2.2% of the country's total healthcare expenditures. CONCLUSION: These findings demonstrate the high economic importance of type 2 diabetes and its complications in Switzerland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Economic Costs of Type 2 Diabetes: A Global Systematic Review
Seuring, T., Archangelidi, O., & Suhrcke, M. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0268-9 · Cited by 837
Ruof, J., Golay, A., Berne, C., Collin, C., Lentz, J., & Maetzel, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802925 · Cited by 40
Benhamza, M., Dahlui, M., & Said, M. A. (2024) · BMC Ophthalmology · doi:10.1186/s12886-024-03665-6 · Cited by 32
“It also highlights the substantial burden imposed by the costs of DM and its related complications on the country [18].”
BackgroundInfluentialTóth, G., Limburg, H., Szabó, D., Sándor, G. L., Nagy, Z. Z., & Németh, J. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316337 · Cited by 11
Metadata
- Authors
- Schmitt-Koopmann, I.
- Venue
- The European Journal of Public Health
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 14
- Issue
- 1
- Pages
- 3-9
- ISSN
- 1101-1262 (ISSN-L)
- 1464-360X
- OpenAlex
- W2112870725
- Cited by
- 58
- References
- 0
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct medical costs of type 2 diabetes and its complications in Switzerland. https://app.cochat.ai/papers/10.1093/eurpub/14.1.3
- The paper
- Schmitt-Koopmann, I. (2004). Direct medical costs of type 2 diabetes and its complications in Switzerland. The European Journal of Public Health. https://doi.org/10.1093/eurpub/14.1.3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.